Supreme Court declines review of Baxter/Fresenius patent row

Fresenius escapes for good a $24 million patent infringement loss to dialysis rival Baxter International after the U.S. Supreme court declines to review the case.

Baxter International, U.S. Supreme Court, Fresenius Medical Care

Legal News, News Well, Dialysis, Patent Infringement

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1gHtJta